DURECT (DRRX): שולי רווח תפעולי

לוגו של חברה ציבורית DURECT Corp (DRRX)

The annual operating margin on the GURU.Markets chart correlates with the implementation of environmental standards in liver research, with the current value standing at -455.00. Yield growth is based on patents that allow the company to exercise pricing power over therapies. Business resilience is ensured by high barriers to entry and strict FDA control over biological developments, which protects the position of DURECT Corporation (DRRX).

DRRX - יחס רווח תפעולי DURECT Corporation בטווח 04.07.2022 - 27.09.2025

פילוחים אנליטיים של חברת DURECT Corporation

- מחיר מניה וקונצנזוס הערכת שווי:
ניתוח פונדמנטלי של החברה:DRRX, DURECT Corp
מוצרים מוגמרים של DURECT Corp

Operating margin measures cost management efficiency, determining the share of profit from core business operations relative to total revenue before accounting for financial obligations and taxes. For DURECT Corporation (DRRX), the average operating margin demonstrates management's ability to monetize developments in epigenetics, allowing investors to assess the sustainability of the business model while creating innovative drugs for organ regeneration.